Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy.
about
Diversity of Intestinal Macrophages in Inflammatory Bowel DiseasesFat, fibre and cancer risk in African Americans and rural AfricansSerum interleukin 17 levels in patients with Crohn's disease: real life data.Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitisMonocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD.Propionate Ameliorates Dextran Sodium Sulfate-Induced Colitis by Improving Intestinal Barrier Function and Reducing Inflammation and Oxidative Stress.Investigational cytokine-targeted therapies for ulcerative colitis.Targeting TNF-α for the treatment of inflammatory bowel disease.Th17 cells in autoimmune diseases.New Insights into the Mechanisms of Action of Anti-Tumor Necrosis Factor-α Monoclonal Antibodies in Inflammatory Bowel Disease.The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.Oleuropein Decreases Cyclooxygenase-2 and Interleukin-17 Expression and Attenuates Inflammatory Damage in Colonic Samples from Ulcerative Colitis Patients.Imbalances of CD4(+) T-cell subgroups in Crohn's disease and their relationship with disease activity and prognosis.Potential role of Th17 cells in the pathogenesis of type 2 autoimmune pancreatitis.Response to infliximab therapy in ulcerative colitis is associated with decreased monocyte activation, reduced CCL2 expression and downregulation of Tenascin C.Quantifying the relative immune cell activation from whole tissue/organ-derived differentially expressed gene data.Partial to complete abrogation of the subepithelial macrophage barrier against the gut microbiota in patients with ulcerative colitis and Crohn's colitis.Effects of arachidonic acid intake on inflammatory reactions in dextran sodium sulphate-induced colitis in rats.TNF and granulocyte macrophage-colony stimulating factor interdependence mediates inflammation via CCL17.The Role of Ultrasound Elasticity Imaging in Predicting Ileal Fibrosis in Crohn's Disease Patients.Peptidoglycan Suppresses Phagocytic Activities and Apoptosis of Macrophages in Colonic Mucosa Tissues of Crohn's Disease Patients and In Vitro.The Role of T-Cell Subsets in Chronic Inflammation in Celiac Disease and Inflammatory Bowel Disease Patients: More Common Mechanisms or More Differences?Identification of inflammatory mediators in patients with Crohn's disease unresponsive to anti-TNFα therapyIndoleamine 2,3-dioxygenase-dependent expansion of T-regulatory cells maintains mucosal healing in ulcerative colitis
P2860
Q26772342-553F733B-7DEA-458A-9DA4-1A6A95D12565Q28261264-4807D2C6-20CF-411A-859F-02A7C69ACEB5Q30843734-46E6EE2A-4161-446B-9103-0FD2B28DAA43Q34437894-39685057-8C2D-4ACB-8713-8AD6D2A63B92Q35611467-3A264DBB-AF6D-467B-A64B-6368584E86F1Q37172417-605F6ECB-F48C-461B-9335-D4C395290BCEQ38117175-C6822F0C-2526-4D73-A0BB-B91916BF7279Q38160905-6D276D63-D66E-4483-877E-D26B69D48279Q38344543-99859B6A-4F35-4C8D-823E-C2895BE65FEFQ38582765-57BD5787-E265-4CA9-9D85-D3F76D43B66EQ38665824-ECB8566E-48EE-4488-9F57-BF245E16327AQ38831798-50BAFB98-CBCD-4099-B153-F83AD5D8779EQ39212377-2208CB3E-72C6-474A-A4EA-048FCB56EE8EQ40477171-35BD9ECF-2245-4DA3-AEAA-C2D6347881C4Q41678385-84DA700F-D9C9-4178-A89F-29EC8583FF45Q41921233-E819B2E4-5FA4-4790-97BD-F154E8596B76Q48201011-F7D6C11B-7FEB-433E-A2A0-7198A7D993D7Q50438967-801A32FE-7C09-4CAF-B227-A69DF5E231A9Q52644010-B1C32A27-1314-411E-95A4-591773EBF112Q53399473-76FE9D0B-36AA-47D9-ABEC-09872261E373Q55159958-E0A9CD0E-E1FB-4E6A-867C-19318F18AF9DQ55222890-60F2CDD8-20BE-4CBD-8163-68AC8A1CAE87Q57239820-B8DAE543-101D-4216-9F3C-F3ACED32DE63Q58707093-8B7288C4-E141-4203-953C-4710A81ECAE9
P2860
Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Reduction of CD68+ macrophages ...... following infliximab therapy.
@en
Reduction of CD68+ macrophages ...... following infliximab therapy.
@nl
type
label
Reduction of CD68+ macrophages ...... following infliximab therapy.
@en
Reduction of CD68+ macrophages ...... following infliximab therapy.
@nl
prefLabel
Reduction of CD68+ macrophages ...... following infliximab therapy.
@en
Reduction of CD68+ macrophages ...... following infliximab therapy.
@nl
P2093
P2860
P50
P1476
Reduction of CD68+ macrophages ...... following infliximab therapy.
@en
P2093
Chiara Viganò
Clorinda Ciafardini
Dario Conte
Francesca Bosè
Gianfranco Altomare
Giovanni Monteleone
Guido Basilisco
Lorenzo Raeli
Luciana Petti
P2860
P304
P356
10.1097/MIB.0B013E318280292B
P577
2013-03-01T00:00:00Z